Endometrial microbiota‐targeted therapies for chronic endometritis‐associated recurrent implantation failure and their impact on IVF outcomes: A systematic review and methodological quality assessment
Acta Obstetricia et Gynecologica Scandinavica · 2026-03 · 105 (3) · 418-435
DOI: 10.1111/aogs.70138 ↗At a glance
Systematische Übersicht in Acta Obstetricia et Gynecologica Scandinavica, published online on 2026-02-13. Written by Bogdan Doroftei and 6 co-authors. Institution: Department of Mother and Child, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania. Major MEDLINE topics: Endometritis, Fertilization in Vitro, Microbiota, Embryo Implantation. Cited 7 times so far (Crossref); 100 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Introduction
Recurrent implantation failure (RIF) is a multifactorial reproductive disorder, often associated with chronic endometritis (CE) and alterations of the intrauterine microbiota. Material and Methods This systematic review evaluated whether microbiota‐targeted therapeutic interventions improve pregnancy outcomes in women with CE‐associated RIF undergoing in vitro fertilization (IVF)‐embryo transfer (ET). Study quality and risk of bias were assessed using the Newcastle‐Ottawa Scale (NOS) and the Revised Cochrane Risk of Bias in Non‐Randomized Studies – of Interventions (ROBINS‐I).
Results
Four studies met the inclusion criteria, encompassing antibiotic, probiotic, and nutraceutical interventions. Considerable heterogeneity was observed in study design, diagnostic criteria, and microbiota assessment methods. Across studies, the reproductive outcomes revealed a clinical pregnancy rate of 50.5% (187/370), ongoing pregnancy rate of 40.1% (107/267), and live birth rate of 41.2% (105/255). Other reported outcomes included seven multiple pregnancies (8.3%), 39 miscarriages (20.0%), 35 biochemical pregnancies (17.9%), and one stillbirth (1.17%).
Conclusions
Microbiota‐targeted treatments may improve reproductive outcomes in women with CE‐associated RIF; however, the limited number of available studies, small sample sizes, and methodological variability reduce the strength of current evidence. High‐quality, prospective, confounder‐adjusted trials with rigorous participant selection processes and standardized, validated diagnostic and implementation criteria are needed to confirm these findings and inform clinical practice.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Mother and Child, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania.
- "Cuza Voda" Clinical Hospital of Obstetrics and Gynecology, Iasi, Romania.
- Origyn Fertility Center, Iasi, Romania.
- Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania.
ORCID profiles: Ovidiu-Dumitru Ilie
Cite
APA
Doroftei, B., Ilie, O. D., Dabuleanu Cretu, A. M., Selaru, I., Lunguleac, G., Doroftei, M., & Ilea, C. (2026). Endometrial microbiota‐targeted therapies for chronic endometritis‐associated recurrent implantation failure and their impact on IVF outcomes: A systematic review and methodological quality assessment. Acta Obstetricia et Gynecologica Scandinavica, 105(3), 418-435. https://doi.org/10.1111/aogs.70138
Vancouver
Doroftei B, Ilie OD, Dabuleanu Cretu AM, Selaru I, Lunguleac G, Doroftei M, et al. Endometrial microbiota‐targeted therapies for chronic endometritis‐associated recurrent implantation failure and their impact on IVF outcomes: A systematic review and methodological quality assessment. Acta Obstetricia et Gynecologica Scandinavica. 2026;105(3):418-435. doi:10.1111/aogs.70138
BibTeX
@article{Doroftei2026,
author = {Doroftei, Bogdan and Ilie, Ovidiu-Dumitru and Dabuleanu Cretu, Ana-Maria and Selaru, Iulia and Lunguleac, Gabriela and Doroftei, Mara and Ilea, Ciprian},
title = {Endometrial microbiota‐targeted therapies for chronic endometritis‐associated recurrent implantation failure and their impact on IVF outcomes: A systematic review and methodological quality assessment},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2026},
volume = {105},
number = {3},
pages = {418--435},
doi = {10.1111/aogs.70138}
}
EUVIMED